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Synthon robustness or lack of structural interference is a sought after goal in crystal engineering.
The crystal structures of saccharinate salts 1–6 show the robustness of the newly identified
hydrogen bonded synthons I and III.
Introduction
Crystal engineering seeks to understand the role of various
non-covalent interactions in the design of solid-state materials
with desired physical and chemical properties.1 Efforts toward
this goal have concentrated on organic molecular solids.2
However, crystal engineering of organic salts3 is also becoming
popular because they contain more easily predicted, ionic,
hydrogen-bonded supramolecular synthons4 and because these
synthons are generally more robust than those in neutral
organics. Salt formation is pertinent to the study of active
pharmaceutical ingredients (API)5 in the context of modula-
tion of properties like solubility, stability, crystal morphology
and bioavailability.6 However, the structural changes that may
take place upon salt formation of an API can be drastic;
accordingly, the changes in the various properties above are
quite unpredictable. Saccharin (pKa 2.2) has been used as an
acid (salt former) in the pharmaceutical industry7 and the
crystal structures, solubility and solution pH characteristics of
several API saccharinates have been discussed by us recently.8
Observed crystal structures result from a balance of several
factors and finding a robust supramolecular synthon in a
family of structures can be a difficult task.9 This paper is a
structural study of a group of pyridyl saccharinates, and
identifies a new and robust supramolecular synthon,10 which is
constructed with N+–H…O and C–H…N2 interactions.
Experimental
Sample preparation and crystallization
Crystallizations of pyridine saccharinates were performed
by slow evaporation. For the preparation of salts 1 and 3,
saccharin was mixed directly with the respective liquid amines.
The mixture was allowed to evaporate at ambient conditions
to give single crystals. For salts 2, 4, 5, 6 and 7 saccharin and
the respective solid amines were dissolved in hot MeOH/
benzene (3 : 1) and left at room temperature to facilitate the
growth of crystals suitable for X-ray diffraction. Salts were
characterized by IR spectra, and with single crystal X-ray
diffraction. Melting points were recorded on a Fisher–Johns
apparatus. Crystallographic data and hydrogen bond metrics
are summarized in Tables 1 and 2 and ORTEP diagrams are
given in Fig. 1.
X-Ray crystallography
X-Ray diffraction intensities for all salts reported in this
paper were collected on a Bruker SMART CCD APEX
diffractometer (Bruker Systems Inc., 1999a)11 using Mo Ka
X-radiation. Data were processed using the Bruker SAINT
package (Bruker Systems Inc., 1999b)12 with structure solution
and refinement using SHELX97 (Sheldrick, 1997).13 The
structures of all the compounds were solved by direct methods
and refined by full-matrix least-squares on F2. H-atoms were
located in all the structures and refined freely with isotropic
displacement parameters. Crystal data and details of data
collection, structure solution and refinement are summarized
in Table 1. Crystallographic data (excluding structure factors)
for the structures reported in this paper have been deposited
with the CCDC as deposition No. CCDC 611646–611652
(see also Table 1). Copies of the data can be obtained, free
of charge, on application to the CCDC, 12 Union Road,
Cambridge CB2 lEZ UK (fax: + 44 (1223) 336 033; e-mail:
deposit@ccdc.cam.ac.uk). For crystallographic data in CIF or
other electronic format see DOI: 10.1039/b608926g
Calculations
All calculations were carried out on Indigo Solid Impact and
Indy workstations from Silicon Graphics. All interatomic
distances, packing coefficients and related calculations were
carried out with the PLATON program.14
Results and discussion
Scheme 1 shows the seven saccharinate salts in this study. In
salts 1–3 the protonated heterocyclic N-atom is the only
hydrogen bond functionality in the cation. In saccharinates
4–7 the presence of additional functionality like amine or
amide perturbs the packing to differing degrees.
Fig. 2 illustrates the crystal structure of pyridyl saccharinate,
1 (space group P1¯). The unsubstituted pyridinium cation forms
both N+–H…O and weak C–H…N2 hydrogen bonds with the
saccharinate anion to give a planar two-point hetero-synthon I
(Scheme 2). This is the prototype synthon in this family, and it
has not been reported previously. Numerous C–H…OLS
interactions provide further stabilisation.
In the 1 : 2 salt, 2, of 4,49-bipyridine and saccharin (P21/c)
the heterocycle lies on an inversion centre and the crystal
structure extends into a linear tape along the a axis via the
saccharin–pyridine hetero-synthon I (Fig. 3). Numerous other
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C–H…O hydrogen bonds and van der Waals interactions
give auxiliary support to the 2-D layer and the interlayer
regions. The crystal structure of 2 is a simple extension of that
of 1. The crystal structure of 4-methylpyridinium saccharinate,
3 (P1¯), is similar to those of 1 and 2. Interestingly, the
asymmetric unit is composed of two molecules of each
component connected with hetero-synthon I (Fig. 4). Clearly
Me-substitution in the 4-position does not alter the hydrogen
bonding dramatically.
In the crystal structures of 4–6 there other hydrogen-
bonding functionalities are present but the overall crystal
structures are still easily understood. In the 1 : 1 salt of
isonicotinamide and saccharin, 4, (P21/c) hetero-synthon I
occurs again but the resulting saccharin–heterocycle units are
connected via amide homo-synthons (II) to form discrete tapes
(Fig. 5). The principles of crystal construction are clear
enough. Synthons I and II are both robust. They occur
together in the crystal structure of 4 without any mutual
interference and the structure is easily understood as a linear
combination of these synthons.
The asymmetric unit of 3-aminopyridinium saccharinate, 5
(P21/n) consists of one molecule of each component connected
by the saccharin–pyridine hetero-synthon I. The –NH2
functionality acts as a bridge between saccharin–heterocycle
dimers by forming an N–H…O hydrogen bond. The result is
shown in Fig. 6.T
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Table 2 Hydrogen bonds in crystal structures of the salts in this study
Compound
Hydrogen
bond d/A˚ (H…A) D/A˚ (X…A) h/u /X–H…A
1 N–H…O 1.64 2.653(3) 176.8
N–H…O 1.63 2.634(3) 174.1
C–H…N 2.68 3.377(3) 121.8
C–H…N 2.63 3.363(4) 124.1
C–H…O 2.25 3.309(4) 164.4
C–H…O 2.28 3.352(4) 170.9
2 N–H…O 1.70 2.707(4) 173.4
C–H…N 2.33 3.131(5) 129.6
C–H…O 2.44 3.154(4) 122.0
3 N–H…O 1.62 2.630(2) 179.0
N–H…O 1.70 2.699(2) 170.9
C–H…N 2.39 3.187(3) 129.2
C–H…N 2.61 3.344(3) 124.2
C–H…O 2.35 3.328(3) 149.3
C–H…O 2.49 3.281(3) 129.0
4 N–H…O 1.68 2.690(3) 174.6
N–H…O 1.98 2.852(3) 142.9
C–H…N 2.45 3.133(3) 120.0
C–H…O 2.36 3.295(3) 144.0
C–H…O 2.39 3.183(3) 128.9
5 N–H…O 2.14 3.116(2) 161.4
N–H…O 2.46 2.919(2) 106.7
N–H…O 1.64 2.644(2) 173.3
C–H…O 2.29 3.040(2) 124.3
6 N–H…O 1.71 2.716(2) 174.4
N–H…O 1.97 2.933(2) 159.3
N–H…N 1.96 2.965(2) 171.8
C–H…O 2.39 3.280(3) 138.2
C–H…O 2.43 3.304(3) 136.3
7 N–H…O 2.94 3.315(3) 103.1
N–H…O 1.80 2.802(3) 172.2
N–H…N 1.83 2.839(2) 176.8
N–H…N 2.09 3.068(3) 162.9
C–H…O 2.46 3.446(3) 151.4
C–H…O 2.46 3.452(3) 151.4
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Fig. 1 Single molecule ORTEP drawings of the saccharinate salts in this paper.
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The crystal structures of 1–5 show that the ‘‘strong–weak’’
N+–H…O and C–H…N2 hydrogen bonded synthon I is a
robust recognition motif that is largely insensitive to the
substitution and placement of other functional groups in the
pyridine fragment. In the crystal structure of 2-aminopyridi-
nium saccharinate, 6, however another supramolecular syn-
thon III appears (Fig. 7). The formation of III is interesting.
The pyridinium N+–H group interacts with the CLO group to
give an N+–H…O hydrogen bond. The amino N–H competes
favourably with the weaker C(sp2)–H donor and an N–H…N2
interaction is formed instead of the C–H…N2 interaction
seen previously in salts 1–5. Incidentally, synthon III was
previously observed by us in the crystal structure of
lamivudine saccharinate.8b
The saccharinate salt, 7, of 2-amino-4,6-dimethylpyrimidine
crystallizes in the space group P1¯ and consists of one molecule
of each component connected with a different type saccharin–
aminopyridine hetero-synthon (Fig. 8). Instead of N+–H…O
and N–H…N2 interactions (as in 6) the system forms
N+–H…N2 and N–H…O interactions (synthon V). Two
saccharin–aminopyrimidine dimers are connected to each
other via an N–H…N homo-synthon IV to form a discrete
unit. These units are connected to each other via bifurcated
C–H…OLS interactions to form a 1-D tape.
In saccharinates 1–5 a pyridinium cation and a saccharinate
anion are linked with N+–H…O and C–H…N2 hydrogen
bonds to form hetero-synthon I (Scheme 2). This is the first
reported occurrence of this synthon, and it is formed with a
variety of heterocyclic bases related to pyridine. A necessaryScheme 2 Some homo-synthons and hetero-synthons in this study.
Fig. 3 Crystal structure of the 4,49-bipyridine saccharin salt, 2.
Compare this with the pyridine salt 1.
Fig. 4 Supramolecular synthon I in the crystal structure of 3. Note
the C–H…OLS hydrogen bonds that interlinks these synthons.
Fig. 5 Perspective views of 4 displaying the saccharin–pyridine
hetero-synthon I and amide–amide homo-synthon II.
Scheme 1 Heterocyclic bases in this study as found in their
saccharinate salts. The numbers refer to the salts in the text.
Fig. 2 Crystal structure of pyridinium saccharinate, 1. Note supra-
molecular synthon I which is built with N+–H…O and C–H…N2
hydrogen bonds.
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condition for hetero-synthon15 formation is that the hydrogen
bonding between the dissimilar functional groups should be
stronger than homo-aggregation. The formation of this
saccharin–pyridine hetero-synthon appears to be very satisfac-
tory because of the strong hydrogen bond donor and acceptor
capability of both the pyridinium cation and the saccharinate
anion. We suggest that formation of the saccharin–pyridine
hetero-synthon is kinetically preferred because the strongest H
bond donor (N+–H of pyridine cation) will readily approach
the CLO group of saccharinate anion. Due to delocalisation,
the charge on the anion is expected to reside on both N- and
O-atoms and arguably, the more electronegative O-atom is the
best acceptor in the system. In general, one might associate the
presence of synthons wherein the hydrogen bond donors and
acceptors are arranged hierarchically (strongest donor to
strongest acceptor, next strongest donor to next strongest
acceptor and so on16) with kinetic control in crystallisation, in
other words with robustness. In a robust system, synthon
formation is relatively insensitive to other molecular function-
ality. This means that a few significant interactions (which
implicitly are the ones formed fastest) dominate the outcome
of crystallisation. Thermodynamic crystals may or may not
follow such hydrogen bond hierarchies depending upon the
nature of the system. When the barrier to the nucleation of the
thermodynamic form is sufficiently high, its formation will be
difficult. When the kinetic and thermodynamic outcome of
crystallisation is identical, polymorphism is unlikely. However,
we have not investigated these latter aspects in this study as
none of the salts displayed polymorphism as far as we could
determine.
Conclusions
Each intermolecular interaction will have some influence on
the result of the crystallization process but it is evident that
some intermolecular interactions are more significant than the
others. The probability that a certain synthon will emerge in
the end could be taken as a measure of the yield of a
supramolecular reaction.17 The crystal structures of seven
hydrogen bonded saccharinate salts have been discussed here.
The N+–H…O interaction between the N+–H group of the
pyridinium cation and the CLO group of the saccharinate
anion is the most important interaction in this family of salts.
At the next level, the aromatic C–H proton interacts with
the saccharin N2. Together these interactions give rise to the
two-point synthon I in saccharinates 1–5. However, in
saccharinates 6 and 7, a second donor functionality namely
NH2, which is a better donor than the aromatic C–H and
which is suitably located in the molecule, interacts with
the saccharin N2 to form synthons III and V respectively.
Consequently, synthons I and III emerge as robust structural
elements in these crystal structures.
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Fig. 7 Supramolecular synthon III in the crystal structure of 6
(Pbca). Note how the N–H…N2 interaction replaces the C–H…N2
interaction in 1–5. As in 3 and 4 the saccharin–aminopyridine hetero-
synthons are connected with C–H…OLS interactions to form a helical
arrangement.
Fig. 8 Crystal structure of 7. Note the 1-D tape which consists of
synthons IV and V.
Fig. 6 Crystal structure of 5 to show hetero-synthon I. Note the
additional N–H…O interaction.
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